Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection

Hepatology

Volumn 36, Issue 6, 2002, Pages 1408-1415

  Chu, Chi Jen ^a   Hussain, Munira ^a   Lok, Anna S F ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINESE; CHRONIC HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DNA DETERMINATION; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; STOP CODON; VIRUS CARRIER;

EID: 0036896285     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.36949     Document Type: Article

References (24)

1. Loeb KR, Jerome KR, Goddard J, Huang ML, Cent A, Corey L. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 2000;32:626-629.
2. Noborg U, Gusdal A, Horal P, Lindh M. Levels of viraemia in subjects with serologic markers of past or chronic hepatitis B virus infection. Scand J Infect Dis 2000;32:249-252.
3. Niitsuma H, Ishii M, Miura M, Kobayashi K, Toyota T. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers. Am J Gastroenterol 1997;92:119-123.
4. Gerken G, Gomes J, Lampertico P, Colombo M, Rothaar T, Trippler M, Colucci G. Clinical evaluation and applications of the Amplicor HBV Monitor™ test, a quantitative HBV DNA PCR assay. J Virol Methods 1998;74:155-165.
5. Fujiwara K, Yokosuka O, Ehata T, Chuang WL, Imazeki F, Saisho H, Omata M. The two different states of hepatitis B virus DNA in asymptomatic carriers: HBeAg-antigen-positive versus anti-HBe-positive asymptomatic carriers. Dig Dis Sci 1998;43:368-376.
6. Lindh M, Horal P, Dhillon AP, Norkrans G. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepatitis 2000;7:258-267.
7. Kessler HH, Preininger S, Stetzl E, Daghofer E, Santner BI, Marth E, Lackner H, et al. Identification of different states of hepatitis B virus infection with a quantitative PCR assay. Clin Diagn Lab Immun 2000;7:298-300.
8. Chu CJ, Lok AS. Clinical utility of quantifying serum HBV DNA levels using PCR assays. J Hepatol 2002;36:549-541.
9. Chan HLY, Leung NWY, Hussain M, Wong ML, Lok ASF. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 2000;31:763-768.
10. Jardi R, Buti M, Rodriguez-Frias F, Cortina M, Esteban R, Guardia J, Pascual C. The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol 1996;24:680-685.
11. Gauthier J, Bourne EJ, Lutz MW, Crowther LM, Dienstag JL, Brown NA, Condreay LD. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Infect Dis 1999;180:1757-1762.
12. Lok AS, Heathcote EJ, Hoofnagle JH. Management of Hepatitis B 2000, Summary of a Workshop. Gastroenterology 2001;120:1828-1853.
13. Martinot-Peignoux M, Boyer N, Colombat M, Akremii R, Pham BN, Castelnau C, Valla D, et al. Serum HBV DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002;36:543-546.
14. Manesis EK, Papatheodoridis GV, Hadziyannis SJ. Serum HBV DNA levels in inactive hepatitis B virus carriers. Gastroenterology 2002;122:2092-2093.
15. Ranki M, Schatzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P. Quantification of hepatitis B virus DNA over a wide range from serum studying viral replicative activity in response to treatment and in recurrent infection. Hepatology 1995;21:1492-1499.
16. Noborg U, Gusdal A, Pisa EK, Hedrum A, Lindh M. Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV Monitor test. J Clin Microbiol 1999;37:2793-2797.
17. Pawlotsky JM, Bastie A, Hezode C, Lonjon I, Darthuy F, Remire J, Dhumeaux D. Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: Performance of three commercial assays. J Virol Methods 2000;85:11-21.
18. Teles SA, Martins RMB, Vanderborght B, Stuyver L, Gasper AMC, Yoshida CFT. Hepatitis B virus: Genotypes and subtypes in Brazilian hemodialysis patients. Artif Organs 1999;23:1074-1078.
19. Grandjacques C, Pradat P, Stuyver L, Chevallier M, Chevallier P, Pichoud C, Maisonnas M, et al. Rapid detection of genotypes and mutations in the pre-core promotor and the pre-core region of hepatitis B virus genome: Correlation with viral persistence and disease severity. J Hepatol 2000;33:430-439.
20. Chu CJ, Hussain M, Lok ASF. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared to hepatitis B virus genotype C. Gastroenterology 2002;122:1756-1762.
21. Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994;198:489-503.
22. Stuyver L, de Gendt S, van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J Gen Virol 2000;81:67-74.
23. Lok AS, Akarca U, Greene S. Mutation in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci U S A 1994;91:4077-4081.
24. Hadziyannis SJ, Vassilopoulos D. Hepatitis e antigen-negative chronic hepatitis B. Hepatology 2001;34:617-624.